IDNA - Krystal Biotech: High Potential Buy-At-Dips Stock May, 25 2022 11:36 AM iShares Genomics Immunology and Healthcare In a bear market, Krystal still shows that strong execution can be lucrative. They will file a BLA this quarter. The market potential is huge. For further details see: Krystal Biotech: High Potential, Buy-At-Dips Stock